sj-docx-1-tam-10.1177_17588359211039930 – Supplemental material for Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis

Müller, Moritz; Posch, Florian; Kiem, Dominik; Barth, Dominik; Horvath, Lena; Stotz, Michael; Schaberl-Moser, Renate; Pichler, Martin; Greil, Richard; Jost, Philipp J.; Seeber, Andreas; Amann, Arno; Schlick, Konstantin; Gerger, Armin; Riedl, Jakob M.

doi:10.25384/SAGE.16713523.v1

sj-docx-1-tam-10.1177_17588359211039930.docx (74.88 kB)

sj-docx-1-tam-10.1177_17588359211039930 – Supplemental material for Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis

journal contribution

posted on 2021-10-01, 00:08 authored by Moritz Müller, Florian Posch, Dominik Kiem, Dominik Barth, Lena Horvath, Michael Stotz, Renate Schaberl-Moser, Martin Pichler, Richard Greil, Philipp J. Jost, Andreas Seeber, Arno Amann, Konstantin Schlick, Armin Gerger, Jakob M. Riedl

Supplemental material, sj-docx-1-tam-10.1177_17588359211039930 for Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis by Moritz Müller, Florian Posch, Dominik Kiem, Dominik Barth, Lena Horvath, Michael Stotz, Renate Schaberl-Moser, Martin Pichler, Richard Greil, Philipp J. Jost, Andreas Seeber, Arno Amann, Konstantin Schlick, Armin Gerger and Jakob M. Riedl in Therapeutic Advances in Medical Oncology